Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion type Assertion NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_head.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion description "[IL-27 was also detected at higher levels in patients with liver cirrhosis or hepatocellular carcinoma than those with acute hepatitis B or chronic hepatitis B (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_provenance.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion evidence source_evidence_literature NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_provenance.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion SIO_000772 19081304 NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_provenance.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion wasDerivedFrom befree-2016 NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_provenance.
- NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_assertion wasGeneratedBy ECO_0000203 NP709216.RAlgo2WFSgLddE1QPqJy_subLEY0NDTgYmM93jon1Nyb4130_provenance.